HZNP

Horizon Pharma plc Press Releases

$12.28
*  
0.15
1.24%
Get HZNP Alerts
*Delayed - data as of Sep. 30, 2014  -  Find a broker to begin trading HZNP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    HZNP After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Horizon Pharma plc Announces Management Executive Committee and Commercial Restructuring Following Close of Acquisition of Vidara Therapeutics International plc
9/26/2014 9:00:00 AM - Market Wire

Horizon Pharma plc to Host Friedreich''s Ataxia Analyst Day on October 13, 2014
9/23/2014 4:05:00 PM - Market Wire

Horizon Pharma plc to Host Friedreich's Ataxia Analyst Day on October 13, 2014
9/23/2014 4:05:00 PM - Market Wire

Horizon Pharma to Present at the 21st Annual NewsMakers in the Biotech Industry Conference
9/22/2014 4:05:00 PM - Market Wire

Horizon Pharma plc Announces Board of Directors Following Closing of Acquisition of Vidara Therapeutics International plc
9/19/2014 10:46:00 AM - Market Wire

Horizon Pharma Completes Acquisition of Vidara Therapeutics International plc
9/19/2014 10:42:00 AM - Market Wire

Horizon Pharma Announces Stockholder Approval of Its Acquisition of Vidara Therapeutics International plc and Expected Transaction Closing on September 19th
9/18/2014 9:16:00 AM - Market Wire

Horizon Pharma to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2014
9/2/2014 7:30:00 AM - Market Wire

Horizon Pharma Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets
8/27/2014 7:30:00 AM - Market Wire

Horizon Pharma Announces U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen / esomeprazole) Delayed Release Tablets
8/13/2014 7:30:00 AM - Market Wire

Horizon Pharma Announces Effectiveness of S-4 Registration Statement for Acquisition of Vidara Therapeutics International Public Company Limited
8/8/2014 7:30:00 AM - Market Wire

Horizon Pharma Reports Second Quarter 2014 Financial Results and Provides Business Update
8/7/2014 6:30:00 AM - Market Wire

Horizon Pharma Announces the U.S. Patent and Trademark Office Issuance of Additional Notices of Allowance With Claims Covering VIMOVO(R) (Naproxen / Esomeprazole) Delayed Release Tablets
8/5/2014 7:30:00 AM - Market Wire

Horizon Pharma to Host Conference Call and Webcast to Discuss Second Quarter 2014 Financial Results on August 7, 2014
7/29/2014 7:30:00 AM - Market Wire